These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 4016775
1. Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study. Shildt R, Stephens RL, Subramanian VP, Baker LH, Fletcher WS, O'Bryan RM, McCracken JD. Cancer Treat Rep; 1985 Jun; 69(6):709-10. PubMed ID: 4016775 [No Abstract] [Full Text] [Related]
2. Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study. Tilchen EJ, Fleming T, Mills G, Oishi N, Bonnett JD, Natale RB, Harker G, Coltman CA. Cancer Treat Rep; 1987 Dec; 71(12):1309-10. PubMed ID: 3690548 [No Abstract] [Full Text] [Related]
3. Phase II trial of diaziquone in advanced renal adenocarcinoma. Hansen M, Gallmeier WM, Vermorken J, Holdener E, Hansen HH, Renard J, Rozencweig M. Cancer Treat Rep; 1984 Dec; 68(7-8):1055-6. PubMed ID: 6744342 [No Abstract] [Full Text] [Related]
7. Phase II evaluation of diaziquone in recurrent head and neck cancer. Kish JA, Ensley J, Al-Sarraf M. Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616 [No Abstract] [Full Text] [Related]
13. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial. Chan C, Bartolucci A, Brenner D, Presant C, Davila E, Carpenter J, Greco FA, Clamon G, Moore J. Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834 [No Abstract] [Full Text] [Related]
19. Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study. Abeloff MD, Finkelstein DM, Chang AY, Camacho FJ, Creech RH, Ettinger DS. Cancer Treat Rep; 1985 Apr; 69(4):451-2. PubMed ID: 3857972 [No Abstract] [Full Text] [Related]
20. Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer Treat Rep; 1987 Sep; 71(9):865-7. PubMed ID: 3476203 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]